These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7625755)

  • 1. Genetic counselling in breast cancer: sensitivity to parameter values and to available information.
    Margaritte-Jeannin P; Essioux L; Bonaïti-Pellié C; Clerget-Darpoux F
    Ann Genet; 1995; 38(1):19-25. PubMed ID: 7625755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segregation and linkage analysis of nine Utah breast cancer pedigrees.
    Bishop DT; Cannon-Albright L; McLellan T; Gardner EJ; Skolnick MH
    Genet Epidemiol; 1988; 5(3):151-69. PubMed ID: 3169523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of susceptibility to breast cancer.
    Hulka BS
    Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
    Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
    Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
    Oros KK; Ghadirian P; Maugard CM; Perret C; Paredes Y; Mes-Masson AM; Foulkes WD; Provencher D; Tonin PN
    Clin Genet; 2006 Oct; 70(4):320-9. PubMed ID: 16965326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of genetic factors for development of breast cancer].
    Chang-Claude J; Eby N; Becher H
    Zentralbl Gynakol; 1994; 116(12):660-9. PubMed ID: 7846977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic epidemiology of bilateral breast cancer: a linkage analysis using the affected-pedigree-member method.
    Haile RW; Goldstein AM; Weeks DE; Sparkes RS; Paganini-Hill A
    Genet Epidemiol; 1990; 7(1):47-55. PubMed ID: 2328913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
    Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
    Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
    Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiparametric linkage analysis using pseudolikelihoods on neighbouring sets.
    Li H; Huang J
    Ann Hum Genet; 1998 Jul; 62(Pt 4):323-36. PubMed ID: 9924610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].
    Klijn JG; Devilee P; van Geel AN; Tilanus-Linthorst MM; Dudok-de Wit C; Meijers-Heijboer EJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):439-45. PubMed ID: 7891765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of risk factor covariates in a segregation analysis of a population-based sample of 426 breast cancer families.
    Grabrick DM; Anderson VE; King RA; Kushi LH; Sellers TA
    Genet Epidemiol; 1999; 16(2):150-64. PubMed ID: 10030398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
    Kaufman DJ; Beaty TH; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.